W World Corp - ESG Rating & Company Profile powered by AI
Jump to the end of the page for potential risks for W World Corp based on sector, location and size. If you work at W World Corp and you would like to use your Sustainability aseessment, please contact us. This Disclosure score covers 17 United Nations Sustainable Development Goals including: 'Gender Equality', 'Industry, Innovation & Infrastructure' and 'Life on Land'.
W World Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | W World Corp | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does W World Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes W World Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes W World Corp report the average age of the workforce?
Sign up for free to unlockDoes W World Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes W World Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes W World Corp disclose cybersecurity risks?
Sign up for free to unlockDoes W World Corp offer flexible work?
Sign up for free to unlockDoes W World Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes W World Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes W World Corp conduct supply chain audits?
Sign up for free to unlockDoes W World Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes W World Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes W World Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes W World Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes W World Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes W World Corp disclose water use targets?
Sign up for free to unlockDoes W World Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid W World Corp have a product recall in the last two years?
Sign up for free to unlockDoes W World Corp disclose incidents of discrimination?
Sign up for free to unlockDoes W World Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas W World Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes W World Corp disclose parental leave metrics?
Sign up for free to unlockDoes W World Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes W World Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes W World Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes W World Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes W World Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes W World Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs W World Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes W World Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes W World Corp disclose its waste policy?
Sign up for free to unlockDoes W World Corp report according to TCFD requirements?
Sign up for free to unlockDoes W World Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes W World Corp disclose energy use targets?
Sign up for free to unlockDoes W World Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes W World Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for W World Corp
These potential risks are based on the size, segment and geographies of the company.
W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent, which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in North Las Vegas, Nevada.